LakeShore Biopharma Co (LakeShore Biopharma Co) Change In Inventory : $-8.56 Mil (TTM As of Sep. 2023)

View and export this data going back to 2023. Start your Free Trial

What is LakeShore Biopharma Co Change In Inventory?

LakeShore Biopharma Co's change in inventory for the quarter that ended in Sep. 2023 was $-5.22 Mil. It means LakeShore Biopharma Co's inventory increased by $5.22 Mil from Mar. 2023 to Sep. 2023 .

LakeShore Biopharma Co's change in inventory for the fiscal year that ended in Mar. 2023 was $-2.63 Mil. It means LakeShore Biopharma Co's inventory increased by $2.63 Mil from Mar. 2022 to Mar. 2023 .

LakeShore Biopharma Co's Total Inventories for the quarter that ended in Sep. 2023 was $29.16 Mil.

Days Inventory indicates the number of days of goods in sales that a company has in the inventory. LakeShore Biopharma Co's Days Inventory for the quarter that ended in Sep. 2023 was 715.40.

Inventory Turnover measures how fast the company turns over its inventory within a year. LakeShore Biopharma Co's Inventory Turnover for the quarter that ended in Sep. 2023 was 0.26.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. LakeShore Biopharma Co's Inventory-to-Revenue for the quarter that ended in Sep. 2023 was 0.75.

LakeShore Biopharma Co Change In Inventory Historical Data

The historical data trend for LakeShore Biopharma Co's Change In Inventory can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

LakeShore Biopharma Co Change In Inventory Chart

LakeShore Biopharma Co Annual Data

Trend

Mar21

Mar22

Mar23

Change In Inventory

-10.56

-14.10

-2.63

LakeShore Biopharma Co Semi-Annual Data
	Mar21	Sep21	Mar22	Sep22	Mar23	Sep23
Change In Inventory	Get a 7-Day Free Trial			-6.27	-7.72	0.69	-3.34	-5.22

LakeShore Biopharma Co Change In Inventory Calculation

Change In Inventory is the difference between last period's ending inventory and the current period's ending inventory.

Change In Inventory for the trailing twelve months (TTM) ended in Sep. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was $-8.56 Mil.

LakeShore Biopharma Co (NAS:LSB) Change In Inventory Explanation

1. Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

LakeShore Biopharma Co's Days Inventory for the quarter that ended in is calculated as:

Days Inventory	=	Average Total Inventories	/	Cost of Goods Sold	*	Days in Period
	=	28.032	/	7.151	*	365 / 2
	=	715.40

2. Inventory Turnover measures how fast the company turns over its inventory within a year.

LakeShore Biopharma Co's Inventory Turnover for the quarter that ended in Sep. 2023 is calculated as

Inventory Turnover	=	Cost of Goods Sold	/	Average Total Inventories
	=	7.151	/	28.032
	=	0.26

3. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

LakeShore Biopharma Co's Inventory to Revenue for the quarter that ended in Sep. 2023 is calculated as

Inventory-to-Revenue	=	Average Total Inventories	/	Revenue
	=	28.032	/	37.421
	=	0.75

LakeShore Biopharma Co Change In Inventory Related Terms

Thank you for viewing the detailed overview of LakeShore Biopharma Co's Change In Inventory provided by GuruFocus.com. Please click on the following links to see related term pages.

LakeShore Biopharma Co (LakeShore Biopharma Co) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » LakeShore Biopharma Co Ltd (NAS:LSB) » Definitions » Change In Inventory

Comparable Companies

Traded in Other Exchanges

H6Z:Germany

Address

38 Yongda Road, Building No. 2, Daxing Biomedical Industry Park, Daxing District, Beijing, CHN, 102629

Website

https://www.yishengbio.com

YS Biopharma Co Ltd is principally engaged in the research, development, manufacturing and sale of vaccines and therapeutic biologics. It developed a PIKA immunomodulating technology platform and a series of product candidates targeting rabies, hepatitis B, influenza and other indications. It is also conducting the production and sale of YSJA, a rabies vaccine, the first aluminium-free lyophilized rabies vaccine that was launched in China. It has one operating segment, which is the development, production, marketing and sale of biopharmaceutical products.